CCTV Investments

Chevron Technology Ventures (CTV), often referred to in historical investment contexts as CCTV Investments, is the corporate venture capital arm of Chevron Corporation. Founded in 1999, the firm invests in early-stage companies and technologies that have the potential to enhance Chevron's core energy business or provide platforms for future growth. While primarily focused on energy and carbon management, CTV has a significant history of investing in the life sciences and biotechnology sectors, particularly where biological processes intersect with industrial applications such as biocatalysis and biofuels. Notable historical investments include the protein engineering company Codexis, which was originally a spin-off from Maxygen. The firm operates several funds, including the Core Venture Fund and the Future Energy Fund, to support innovation across the energy transition and industrial biotechnology landscapes.